Paul Price

Dr. Price joined Merrill Lynch in 1987 and over the next 13 years worked with A.G. Edwards, Wheat First and Ferris, Baker Watts. Dr. Price enjoyed enough success to retire in October 2000, but he continues to write and give investment seminars.

Recent Articles By The Author

Organic Food, Bargain Price

Organic Food, Bargain Price

This value stock is a healthy choice.

An 'Under the Radar' Growth Stock

An 'Under the Radar' Growth Stock

Panasonic's lack of visibility has created a nice entry point for investors and traders.

'Death by Amazon' Greatly Exaggerated

'Death by Amazon' Greatly Exaggerated

Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.

Don't Talk Turkey: Play Chicken Instead

Don't Talk Turkey: Play Chicken Instead

This play on Pilgrim's Pride chicken producers is low risk, based on fundamentals.

A Look at My Investing Strategies

A Look at My Investing Strategies

Here's an example of a multi-legged position in Infosys that I put money into last October.

A Look at My Investing Strategies

A Look at My Investing Strategies

Here's an example of a multi-legged position in Infosys that I put money into last October.

Easy Way to Supercharge Annualized Returns

Easy Way to Supercharge Annualized Returns

Try a buy/write options strategy for big potential reward with reduced risk.

Profit From Experience

Profit From Experience

Synchrony is in a similar position to that of American Express a few years ago.

CAH Is Among the Best Blue Chip Values

CAH Is Among the Best Blue Chip Values

Buy Cardinal Health and give it time for the market to reassess the industry.

Dentsply: Say 'Aaagh, Great Opportunity'

Dentsply: Say 'Aaagh, Great Opportunity'

XRAY's long-term record suggests its sharp pullback was/is still a good buying chance.